Comparing the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients

S Hashemipou; S Pourmohammad; L Ghanei; N Esmailzadehha; A Javadi

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Support Contact Us

Authors Guide Submit Manuscript

Comparing the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients

Author(s):

S Hashemipou,

S Pourmohammad^,*,

L Ghanei,

N Esmailzadehha,

A Javadi

Journal of Inflammatory Diseases:Vol. 17, issue 2; 4-10

Article type:Research Article

How to Cite:S HashemipouS PourmohammadL GhaneiN EsmailzadehhaA JavadiComparing the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients.J Inflamm Dis.17(2):e155751.

Abstract

Background: Insulin is administered for glycemic control in type 2 diabetic patients with secondary failure to oral antidiabetic drugs . Achieving good glycemic control requires a long time with relatively high insulin dose. Objective: The aim of this study was to compare the effect of treatment with insulin alone versus insulin plus sulfonylurea in type 2 diabetic patients . Methods: In this randomized clinical trial, 45 patients with secondary failure to oral antidiabetic drugs who referred to Bou-Ali hospital during 2009-2010, were randomly allocated into two groups of insulin alone and insulin plus sulfonylurea. Fasting and postprandial blood sugar, insulin dose, and weight gain were measured monthly up to 3 months. Data were analyzed by T-test and Chi-square test. Findings: A t the end of the first and the third month of the treatment, mean fasting blood sugar was 146.3 ±21.1 mg/dl and 126.9±10.2 mg/dl in combination therapy group and was 166.1 ± 28.7 mg/dl and 144.5 ± 20.9 mg/dl in insulin alone group, respectively ( P =0.01 and P=0.001, respectively). Mean postprandial blood sugar in combination group was lower than insulin alone group at the end of the third month (P=0.009). The difference in mean insulin dose between 2 groups was statistically significant at the end of the third month (P

Keywords

Diabetes Mellitus Type 2

Insulin

Sulfonylurea

comments